BioForce Nanosciences Holdings, Inc.
BFNH
$0.8004
-$0.0062-0.77%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.01% | 8.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.01% | 8.36% | |||
| Operating Income | 8.01% | -8.36% | |||
| Income Before Tax | 86.86% | -658.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 86.86% | -658.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 86.86% | -658.69% | |||
| EBIT | 8.01% | -8.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 87.24% | -590.48% | |||
| Normalized Basic EPS | 11.54% | 0.00% | |||
| EPS Diluted | 87.24% | -590.48% | |||
| Normalized Diluted EPS | 11.54% | 0.00% | |||
| Average Basic Shares Outstanding | 3.95% | 10.16% | |||
| Average Diluted Shares Outstanding | 3.95% | 10.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||